scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00334457 |
P698 | PubMed publication ID | 8480516 |
P2093 | author name string | Y Mizutani | |
M Yokochi | |||
K Hayashida | |||
S Oyanagi | |||
P2860 | cites work | Idiopathic Parkinson's disease and the Lewy body disorders | Q39503766 |
Ultrastructure of Lewy bodies in the stellate ganglion | Q39987734 | ||
Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study | Q40095790 | ||
Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease | Q48169432 | ||
The Lewy body in Parkinson's disease. | Q48254020 | ||
Relationships between Lewy bodies and pale bodies in Parkinson's disease | Q48600286 | ||
Depigmentation in the nerve cells of the substantia nigra and locus ceruleus in Parkinsonism | Q48603493 | ||
Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects | Q48697227 | ||
New pathologic observations in juvenile onset parkinsonism with dystonia | Q48710035 | ||
Juvenile parkinsonism: a case with first clinical manifestation at the age of six years and with neuropathological findings suggesting a new pathogenesis. | Q48772736 | ||
Ultrastructural observations in Parkinsonism | Q51160729 | ||
Neuronal inclusions of Parkinson's disease | Q67914362 | ||
Atypical senile dementia with widespread Lewy type inclusion in the cerebral cortex | Q72848189 | ||
P433 | issue | 4 | |
P921 | main subject | substantia nigra | Q753278 |
Parkinson's disease | Q11085 | ||
autopsy | Q41482 | ||
P304 | page(s) | 445-448 | |
P577 | publication date | 1993-01-01 | |
P1433 | published in | Acta Neuropathologica | Q343168 |
P1476 | title | An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism | |
P478 | volume | 85 |
Q34989985 | A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration |
Q35138501 | Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis |
Q30481396 | Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae |
Q40262236 | Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress |
Q36329444 | Autophagy and neuronal cell death in neurological disorders |
Q90240136 | Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase |
Q64251001 | Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease |
Q92576096 | Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice |
Q30607522 | Formation of α-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes |
Q44195128 | Genetic epidemiology of Parkinson's disease |
Q28287237 | Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies |
Q22252807 | Intraneuronal dopamine-quinone synthesis: A review |
Q34478663 | Lewy bodies |
Q35840040 | Lewy-body formation is an aggresome-related process: a hypothesis |
Q47801119 | Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells |
Q34073890 | Lys-63-linked ubiquitination by E3 ubiquitin ligase Nedd4-1 facilitates endosomal sequestration of internalized α-synuclein |
Q35412397 | Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First? |
Q64869820 | Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease |
Q50532472 | Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals. |
Q92465171 | Parkinson's disease: proteinopathy or lipidopathy? |
Q34995015 | Parkinson's genetics: molecular insights for the new millennium. |
Q43940212 | Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. |
Q30479870 | Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI. |
Q34117600 | The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein. |
Q37003482 | The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates |
Q36423369 | The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis |
Q89790112 | The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration |
Search more.